Trinchieri et al. (2011)22 calculated the total intensity score for all the patients in each group before and after treatment, reporting that Lactobacillus brevis CD2 lozenges were more effective in reducing ulcer severity compared with the placebo group. The gene discussed is CD2; the disease is ulcer disease.